October 31, 2025

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 37.10% Potential Upside

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, has captured investor attention with its pioneering work in T cell redirecting immunotherapies. With..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring an 80% Upside Amidst Robust Revenue Growth

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology firm based in San Diego, is currently capturing the attention of investors with its promising potential upside of 80.22%...

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Biotech with a 108.94% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at the forefront of the biotechnology sector, focusing on the development of gene therapies for rare and life-threatening diseases. With..

Talkspace, Inc. (TALK) Stock Analysis: Revenue Growth Shines with a 65.52% Upside Potential

As investors increasingly focus on the digital transformation of healthcare services, Talkspace, Inc. (NASDAQ: TALK) stands out as a noteworthy player in the virtual behavioral health..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Biotech Gem with 118% Potential Upside

Spyre Therapeutics, Inc. (SYRE) has captured the attention of investors with its significant potential upside of 118.09%, as suggested by the average target price set by..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 65.97% Potential Upside in the Biotech Sector

Pharvaris N.V. (PHVS), a late-stage biopharmaceutical company located in Zug, Switzerland, is capturing significant attention from investors in the biotechnology industry. With a market capitalization of..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring the 55% Potential Upside in the Medical Device Market

Butterfly Network, Inc. (NASDAQ: BFLY) is capturing attention in the healthcare sector with its innovative approach to ultrasound imaging solutions. As a company at the intersection..

Enhabit, Inc. (EHAB) Stock Analysis: Unveiling a Potential 14.61% Upside in Healthcare Services

Enhabit, Inc. (EHAB), a prominent player in the healthcare sector, operates within the medical care facilities industry, providing essential home health and hospice services across the..

Nutex Health Inc. (NUTX) Investor Outlook: A Rising Healthcare Star with 94% Potential Upside

Nutex Health Inc. (NUTX) is capturing the attention of investors with its promising growth trajectory in the healthcare sector. As a company that operates in the..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Unveiling a 72% Potential Upside in the Biotechnology Sector

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment and its substantial..

Kura Oncology, Inc. (KURA) Investor Outlook: Exploring a 158% Upside Potential in Biotech Innovation

Investors keen on high-growth potential in the biotech sector might find Kura Oncology, Inc. (NASDAQ: KURA) an intriguing prospect. With a market capitalization of $906.16 million,..

Oculis Holding AG (OCS) Stock Analysis: A 111.78% Upside Potential with Strong Buy Ratings

Oculis Holding AG (OCS) is capturing the attention of investors with its compelling growth story and a remarkable 111.78% potential upside, according to recent analyst ratings...

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a 41.89% Potential Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a dynamic player in the biotechnology sector, is drawing attention with a sizable potential upside of 41.89%, according to analyst ratings...

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 26.68% Potential Upside for Investors

Investors with an eye on the healthcare sector might find Owens & Minor, Inc. (NYSE: OMI) an intriguing prospect, especially with its potential upside of 26.68%..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 447.95% Potential Upside in the Biotech Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a prominent player in the biotechnology industry, presents an intriguing investment opportunity, particularly for those with an appetite for high-risk,..

Savara, Inc. (SVRA) Stock Analysis: Biotechnology Investor Outlook with a 139.83% Potential Upside

Savara, Inc. (NASDAQ: SVRA) is capturing attention in the biotechnology sector, offering a compelling narrative for investors focused on high-growth potential within the healthcare industry. With..

Sionna Therapeutics, Inc. (SION) Stock Analysis: What Investors Need to Know About This $1.68 Billion Biotech Company

Sionna Therapeutics, Inc. (NASDAQ: SION) is attracting significant attention in the biotech sector, thanks to its promising portfolio aimed at treating cystic fibrosis (CF). With a..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 7.96% Potential Upside in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in creating innovative MRI-compatible medical devices. With a market capitalization of approximately $972 million,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating Potential Upside in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) has emerged as a formidable player in the healthcare sector, particularly within the niche of drug manufacturing for specialty and..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 109.62% Upside Potential

Nurix Therapeutics, Inc. (NRIX), a leading player in the biotechnology sector, is capturing attention with its remarkable potential for substantial growth. Based in San Francisco, the..

Search

Funds

October 31, 2025

Search

Funds

October 31, 2025

FTSE 100

Funds